First Deuterated Drug Approved

In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.

June 2017 sw_admin 0

Zika in the United States: How Are We Preparing?

Once considered an inconsequential illness, Zika is now linked with serious health effects including microcephaly and Guillain-Barré syndrome. As the virus makes its way northward, U.S. public health agencies are doing their best to prepare.

September 2016 sw_admin 0
1 2 3 7